| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |